Page last updated: 2024-10-25

ciprofloxacin and Leukemia P388

ciprofloxacin has been researched along with Leukemia P388 in 1 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thadepalli, H1
Reddy, U1
Chuah, SK1
Hanna, N1
Rana, G1
Gollapudi, S1

Other Studies

1 other study available for ciprofloxacin and Leukemia P388

ArticleYear
Evaluation of trovafloxacin in the treatment of Klebsiella pneumoniae lung infection in tumour-bearing mice.
    The Journal of antimicrobial chemotherapy, 2000, Volume: 45, Issue:1

    Topics: Animals; Anti-Infective Agents; Antibiotics, Antineoplastic; Ciprofloxacin; Daunorubicin; Drug Evalu

2000